These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30771861)

  • 21. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians.
    Manson JE; Grobbee DE; Stampfer MJ; Taylor JO; Goldhaber SZ; Gaziano JM; Ridker PM; Buring JE; Hennekens CH
    Am J Med; 1990 Dec; 89(6):772-6. PubMed ID: 2252045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognosis in stable angina; medical treatment or coronary revascularization in patients younger than 70 years?
    Carpeggiani C; Landi P; Michelassi C; Barberini E; L'Abbate A
    Int J Cardiol; 2011 Apr; 148(1):43-7. PubMed ID: 19913308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
    Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experience.
    Kjøller-Hansen L; Steffensen R; Grande P
    Scand Cardiovasc J; 1998; 32(4):225-32. PubMed ID: 9802141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results following percutaneous myocardial laser therapy.
    Salem M; Rotevatn S; Nordrehaug JE
    Coron Artery Dis; 2006 May; 17(4):385-90. PubMed ID: 16707963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
    Coleman CI; Freemantle N; Kohn CG
    BMJ Open; 2015 Nov; 5(11):e008861. PubMed ID: 26546142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.
    Muhlestein JB; Grehan S
    Drugs R D; 2013 Sep; 13(3):207-13. PubMed ID: 23990357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
    Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
    Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
    Cohen DJ; Van Hout B; Serruys PW; Mohr FW; Macaya C; den Heijer P; Vrakking MM; Wang K; Mahoney EM; Audi S; Leadley K; Dawkins KD; Kappetein AP;
    N Engl J Med; 2011 Mar; 364(11):1016-26. PubMed ID: 21410370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.
    Grodzinsky A; Kosiborod M; Tang F; Jones PG; McGuire DK; Spertus JA; Beltrame JF; Jang JS; Goyal A; Butala NM; Yeh RW; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28904076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.
    Nguyen DD; Spertus JA; Alexander KP; Newman JD; Dodson JA; Jones PG; Stevens SR; O'Brien SM; Gamma R; Perna GP; Garg P; Vitola JV; Chow BJW; Vertes A; White HD; Smanio PEP; Senior R; Held C; Li J; Boden WE; Mark DB; Reynolds HR; Bangalore S; Chan PS; Stone GW; Arnold SV; Maron DJ; Hochman JS;
    J Am Coll Cardiol; 2023 May; 81(17):1697-1709. PubMed ID: 37100486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of PCI on quality of life in patients with stable coronary disease.
    Weintraub WS; Spertus JA; Kolm P; Maron DJ; Zhang Z; Jurkovitz C; Zhang W; Hartigan PM; Lewis C; Veledar E; Bowen J; Dunbar SB; Deaton C; Kaufman S; O'Rourke RA; Goeree R; Barnett PG; Teo KK; Boden WE; ; Mancini GB
    N Engl J Med; 2008 Aug; 359(7):677-87. PubMed ID: 18703470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranolazine for Symptomatic Management of Microvascular Angina.
    Rayner-Hartley E; Parvand M; Humphries KH; Starovoytov A; Park JE; Sedlak T
    Am J Ther; 2020; 27(2):e151-e158. PubMed ID: 29746286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy.
    Slavich M; Maranta F; Fumero A; Godino C; Giannini F; Oppizzi M; Colombo A; Fragasso G; Margonato A
    Am J Cardiol; 2016 May; 117(10):1558-1561. PubMed ID: 27055755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris.
    Landolfo CK; Landolfo KP; Hughes GC; Coleman ER; Coleman RB; Lowe JE
    Circulation; 1999 Nov; 100(19 Suppl):II128-33. PubMed ID: 10567291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.